The current options in the management of actinic keratosis

Giornale Italiano di Dermatologia e Venereologia

Volumn 144, Issue 4, 2009, Pages 445-452

  Larko O ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cryosurgery; Imiquimod; Keratosis, actinic, therapy

Indexed keywords

AMINOLEVULINIC ACID; DICLOFENAC; FLUOROURACIL; IMIQUIMOD;

ACTINIC KERATOSIS; CARBON DIOXIDE LASER; CRYOSURGERY; CRYOTHERAPY; ERBIUM YAG LASER; HUMAN; PHOTODYNAMIC THERAPY; PROGNOSIS; REVIEW; SKIN ABRASION; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE;

EID: 72249099245     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Cancer incidence in Sweden 2004. The National Board of Health and Welfare.
2. Krouse RS, Alberts DS, Prasad AR, Yozwiak M, Bartels HG, Liu Y et al. Progression of skin lesions from normal skin to squamous cell carcinoma. Anal Quant Cytol Histol 2009;31:17-25.
3. Schwartz RA, Bridges TM, Butani AK, Ehrlich A. Actinic keratosis: an occupational and environmental disorder. J Eur Acad Dermatol Venereol 2008;22:606-615 (Pubitemid 351541058)
4. Eskelinen A, Halme K, Lassus A, Idänpäan-Heikkilä J. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA. Photodermatol 1985;2:10-14 (Pubitemid 15173425)
5. Heim K, Widschwendter A, Szedenik H, Geier A, Christensen ND, Bergant A et al. Specific serologic resonse to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions. Am J Obstet Gynecol 2005;192:1073-1083 (Pubitemid 40487781)
6. Cockerall CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000;42:11-17
7. Lindelöf B, Sigurgeirsson B, Gäbel H, Stem RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513-519 (Pubitemid 30743335)
8. Quatresooz P, Xhauflaire-Uhoda E, Piérard-Franchimon C, Piérard GE. Epidermal field carcinogenesis in bald-headed: An attempt at fine- tuning early non-invasive detection. Oncol Rep 2009;21:1313-1316
9. Czarnecki D, Staples M, Mar A, Giles G, Meehan C. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology 1994;189:52-54 (Pubitemid 24126372)
10. Joseph MG, Zulueta WP, Kennedy PJ: Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome. Austr N Z J Surg 1992;62:697-701.
11. Stockfleth E, Kerl H. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006;16:599-606.
12. Anwar J, Wrone DA, Kimyai-Asadi A, Alam M. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes. Clin Dermatol 2004;22:189-196 (Pubitemid 38950745)
13. deBerker D, McGregor JM, Hughes BR, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol 2007;156:222-30.
14. Thai KE, Fergin P, Freeman M, Vinciullo C, Francis D, Spelman L et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol 2004;43:687-692
15. McIntyre WJ, Downs MR, Bedwell SA. Treatment options for actinic keratoses. AmFam Physician 2007;76:667-671
16. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermato 2002;47:258-62.
17. Wang I, Bendsoe N, Klinteberg CA, Enejder AM, Andersson-Engels S, Svanberg S, Svanberg K. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001;144:832-840 (Pubitemid 32374789)
18. Lindgren G, Larkö O. Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol 1997;36:742-746
19. Freeman M, Vinciullo C, Francis D, Spelamn L, Njuyen R, Fergin P et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvx) with a single cycle cryotherapy in patients with actinic keratosis: a prspective randomized study. J Dermatolog Treat 2003;14:99-106. (Pubitemid 36648700)
20. Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003;48:227-232
21. Morton CA, McKenna KE, Rhodes LE, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Guidelines for topical photodynamic therapy: update. Br j Dermatol 2008;159:1245-1266
22. Korman N, Moy R, Ling M. Matheson R, Smith S, McKane S et al. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol 2005;141:467-473 (Pubitemid 40547405)
23. Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double -blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 2004;51:547-55.
24. Stockfleth E, Sterry W, Carey-Yard M, Bichel J. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. Br J Dermatol 2007;157:41-46
25. Jury CS, Ramraka-Jones VS, Gudi V, Herd RM. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment. Br J Dermatol 2005;153:808-810
26. Kurwa HA, Yong-Gee SA, Seed PT, Markey AC, Barlow BJ. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999;41:414-418
27. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol 2000;42:25-28
28. Rivers JK, Rosoph L, Provost N, Bissonnette R. Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head. J Cutan Med Surge 2008;12:97-101.
29. Kose O, Koc E, Erbil AH, Caliskan E, Kurumlu Z. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis. J Dermatolog Treat 2008;19:159-163 (Pubitemid 351882995)
30. Zeichner JA, Stern DW, Uliasz A, Itenberg S, Lebwohl M. Placebo-controlled. Double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses. J Am Acad Dermatol 2009;60:59-62.
31. Patel MJ, Stockfleth E. Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 5% gel, an old drug in a new environment? Br J Dermatol 2007;156:53-56
32. Wennberg AM, Larkö O, Lönnroth P, Larson G. Krogstad AL. Delta-aminolevulinic acid in superficial basal cell carcinomas and normal skin - a microdialysis and perfusion study. Clin Exp Dermatol 2000;25:317-322
33. Sandberg C, Halldin CB, Erikson MB, Larkö O, Krogstad AL. Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo. Br J Dermatol 2008;159:1170-1176
34. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminole-vulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 1997;65:235-251 (Pubitemid 27158805)
35. Kennedy JC, Potter RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990;6:143-148
36. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992;30:275-292
37. Rud E, Gederaas O. Hogset A, Berg K. 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 2000;71:640-647
38. Gederaas OA; Holroyd A. Brown SB, Vernon D, Moan J, Berg K. 5-aminolaevulinic acid methyl ester transport on amino acid carriers in a human colon adenocarcinoma cell line. Photochem Photobiol 2001;73:164-169
39. Rodriguez L, Batlle A. Di Venosa G, Battah S, Dobbin P, Macrobert AJ et al. Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br J Pharmacol 2006;147:825-833
40. Ericson MB, Sandberg C, Gudmundson F, Rosén A, Larkö O, Wennberg AM. Fluorescence contrast and threshold limit: implications for photodynamic diagnosis of basal cell carcinoma. J Photochem Photobiol B 2003;69:121-127 (Pubitemid 36336467)
41. Angell-Petersen E, Sorensen R, Warloe T, Soler AM, Moan J, Peng O et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006;126:265-271 (Pubitemid 43323159)
42. Divaris DX, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 1990;136:891-897
43. Soler AM, Angell-Petersen E, Warloe T, Tausjo J, Steen HB, Moan J et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol 2000;71:724-729
44. Bender J, Ericson MB, Merclin N, Iani V, Rosén A, Engström S et al. Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control Release 2005;106:350-360 (Pubitemid 41187444)
45. Salva KA. Photodynamic therapy: unapproved uses, dosages, or indications. Clin Dermatol 2002;20:571-581 (Pubitemid 35341690)
46. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007;56:125-143
47. Zelickson B, Counters J, Coles C, Selim M. Light patch: preliminary report of a novel form of blue light delivery for the treatment of actinic keratosis. Dermatol Surg 2005;31:375-378 (Pubitemid 43073003)
48. Wang I, Bauer B, Andersson-Engels S, Svanberg S, Svanberg K. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. Acta Ophtalmol Scand 1999;77:182-188
49. Wennberg AM, LKindholm LE, Alpsten M, Larkö O. Treatment of superficial basal cell carcinoma using topically applied delta-aminolaevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996;288:561-564
50. Varma S, Wilson H, Kurwa HA, Gambles B, Charman C, Pearse AD et al. Bowen's disease, solar keratoses and superficial basal cell-carcinomas treated bly photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001;144:567-574 (Pubitemid 32232013)
51. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003;19:134-141 (Pubitemid 36889801)
52. Kim HS, Yoo JY, Cho KH, Kwon OS, Moon SE. Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: clinical and histopathologic evaluation. Dermatol Surg 2005;31:33-36 (Pubitemid 40094058)
53. Gold MH, Bradshaw VL, Boring MM, Bridges TM. Biron JA. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006;32:795-801. (Pubitemid 43847114)
54. Strasswimmer J, Grande DJ. Do pulsed lasers produce an effective photodynamic therapy response? Lasers Surg Med 2006;38:22-25
55. Yang CH, Lee JC, Chen CH, Hui CY, Hong HS, Kuo HW. Photodynamic therapy for bowenoid paulosis using a novel incoherent light-emitting diode device. Br J Dermatol 2003;149:1297-1299
56. Ericson MB, Sandberg C, Stenquist B, Gudmundson F, Karlsson M, Ros AM et al. Photodynamic thrapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 2004;151:1204-1212
57. Tromberg BJ, Orenstein A, Kimel S, Barker SJ, Hyatt J, Nelson JS et al. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem Photobiol 1990;52:375-385
58. De Haas ER, Kruijt B, Sterenborg HJ, Martino Neumann HA, Robinson DJ. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J Invest Dermatol 2006;126:2679-2686
59. Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB; Phase IV ALA-PDT Actinic Keratosis Study Group. Photodynamic therapy using aminolevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 2006;155:1262-1269 (Pubitemid 44730005)
60. Piacquadio DJ, Chen DM, Farber HF, Fowler JF Jr, Glazer SD, Goodman JJ et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase3, multicenter trials. Arch Dermatol 2004;140:41-46
61. Sandberg C, Stenquist B, Rosdahl I, Ros AM, Synnerstad I, Karlsson M et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006;86:404-408 (Pubitemid 44450094)
62. Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Dermatol Venereol 2005;85:424-428 (Pubitemid 41345617)
63. Dragieva G, Hafner J, Dummer R, Schmid-Gredelmeier P, Roos M, Prinz BM et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004;77:115-121
64. Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Dermatol Venereol 2006;86:25-28 (Pubitemid 46939784)
65. Wennberg AM, Stenquist B, Stockfleth E, Keohane S, Lear JT, Jemec G et al. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: randomized study. Transplantation 2008;86:423-429
66. Perrett CM, McGregor JM, Warwick J, Karran P, Leight IM, Proby CM et al. Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 2007;156:320-328
67. deGraaf YG, Kennedy C, Wolterbeek R, Collen AF, Willemze R, Bouwes Bavinck JN. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma n organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 2006;126:569-574
68. Grapengiesser S, Ericson M, Gudmundsson F, Larkö O, Rosén A, Wennberg AM. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002;27:493-497 (Pubitemid 35278943)
69. Wiegelt SR, Stender IM, Na R, Wulf HC. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulin- ic acid methylester on tape-stripped normal skin. Arch Dermatol 2003;139:1173-1177
70. Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008;158:727-733
71. Wiegell SR, Haedersdal M, Philipsen PA, Eriksen P, Enk, CD, Wulf HC. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled single-blinded study. Br J Dermatol 2008;158:740-746
72. Wiegell SR, Haedersdal M, Wulf HC. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Dermatol Venereol 2009;89:145-149
73. Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen's disease: an effective addition to treatment: a pilot study. Dermatol Surg 2004;30:63-66
74. Holmes MV, Dawe RS, Ferguson J, Ibbotson SH. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol 2004;150:337-340 (Pubitemid 38352473)
75. Skiveren J, Haedersdal M, Philipsen PA, Wiegell SR, Wulf HC. Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. Acta Derm Venereol 2006;86:409-411
76. Halldin CB, Paoli J, Sandberg C, Gonzalez H, Wennberg AM: Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp. Br J Dermatol 2009;160:795-800.
77. Paoli J, Halldin C, Ericson MB, Wennberg AM. Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol 2008;33:559-564
78. Halldin CB, Paoli J, Sandberg C, Ericson MB, Wennberg AM. Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy of actinic keratoses. Acta Derm Venereol 2008;88:311-313